Article Information
- Received August 8, 2001
- Revision received September 13, 2001
- Accepted September 19, 2001
- First published December 1, 2001.
- Version of record published December 1, 2001.
Author Information
Author contributions
Disclosures
- Received August 8, 2001.
- Revision received September 13, 2001.
- Accepted September 19, 2001.
This research was performed at Brookhaven National Laboratory and was supported by United States Department of Energy Office of Biological and Environmental Research Grant DE-AC02-98CH10886, National Institute on Drug Abuse Grants DA06891, DA7092-01, and DA00280, General Clinical Research Center (GCRC) at Harbor–University of California, Los Angeles Medical Center National Institutes of Health Grant MO1RR 00425, GCRC at University Hospital Stony Brook National Institutes of Health Grant MO1RR 10710, and the Office of National Drug Control Policy. We thank D. Schlyer and R. Carciello for Cyclotron operations, D. Warner for PET operations, C. Wong for data management, R. Ferrieri, C. Shea, R. MacGregor, V. Garza, and P. King for radiotracer preparation and analysis, and N. Pappas, N. Netusil, and Pauline Carter for patient care.
Correspondence should be addressed to Nora D. Volkow, Medical Department, Brookhaven National Laboratory, Upton, NY 11973. E-mail:volkow{at}bnl.gov.
